IRTC · iRhythm Holdings, Inc.
$122.44
+5.07 (+4.32%)
At close · Jul 29
Market Cap
$4.02B
Shares
32.86M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$122.44
Open$116.31
Day$116.31–123.75
52W$100.85–212.00
Avg vol 30d594K
Short int3.4M · 10.4% float · 5.8d
Short vol60%
Last earningsAug 6, 2026
DataJan 2020–Jul 2026
Filing10-Q · Apr 30
Up next
Next earnings call
Aug 6, 2026
Scheduled
· in 1 wks
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed Apr 30, 2026
AI Brief
TL;DR.
Bullish
Bearish
From the call
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Ask ALVIS about this →Equibles Rating
blended score · not investment adviceOverall
Sell
SellHoldBuy
Technical
Neutral
Momentum
Weak
Sentiment
Bearish
Fundamentals
Excellent
Quant / Vol
Very High
Market backdrop
VIX 20.7 · elevated
Equity put/call 0.61
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−14%
below
Price vs 50-day avg
+8%
above
RSI (14)
61
neutral
MACD trend
Positive
52-week position
19%
mid-range
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
+3%
trailing
6-month return
−20%
trailing
YTD return
−31%
this year
Relative strength
−26%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $114 › 200d $142 — 200d above 50d
Institutional flow
Distributing
68 of 304 funds reported for Jun 30 · net -111.1K sh shares · +9 new
Insider flow
Distributing
Net -$1.2M over 90 days · 86% sells
Short interest
Rising
10.44% of float · ▲ +6.0% MoM · 5.8 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
304 holders — mid 3-yr range
Squeeze score
84
high risk · 0–100
Fundamentals
Revenue growth
+26%
Y/Y
Gross margin
71%
expanding
EPS growth
+62%
Y/Y
Free cash flow
$34.5M
Balance sheet
$201.1M
net cash
Quant / Vol
risk profile
Volatility
45%
annualized · 1-yr
Max drawdown
−46%
past year
ATR
4.4%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Latest guidance
· from the 8-K filed Apr 30, 2026
Revenue
· full year 2026
Maintained
$875M – $885M
prior FY $747.14M
midpoint +17.8% Y/Y
Adjusted EBITDA margin
· full year 2026
Non-GAAP
Initiated
12% – 13%
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders Neutral
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−14%
Bearish
Price vs 50-day avg
+8%
Bullish
RSI (14)
61
Neutral
MACD trend
Positive
Bullish
52-week position
19%
Neutral
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Bearish · 3 of 6
Trend (MA cross)
No cross
50d $114 › 200d $142 — 200d above 50d
Institutional flow
Distributing
68 of 304 funds reported for Jun 30 · net -111.1K sh shares · +9 new
Insider flow
Distributing
Net -$1.2M over 90 days · 86% sells
Short interest
Rising
10.44% of float · ▲ +6.0% MoM · 5.8 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
304 holders — mid 3-yr range
Price context
position in its 52-week range
52-wk low $101
Now $122 · 19%
52-wk high $212
vs 200-day avg -14%
vs 50-day avg +8%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from its earnings releases, calls, and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Adjusted EBITDA non-GAAP | $14.1M | first quarter 2026 | — |
|
|
|||
| Adjusted EBITDA margin non-GAAP | 7.1% | first quarter 2026 | — |
|
|
|||
| Free cash flow non-GAAP | $34.5M | Full Year 2025 | — |
Figures exactly as the company stated them · click a metric with a to chart its history · period links open the stating document · "call" marks figures stated on the earnings call, "filing" figures stated in the 10-K/10-Q · YoY needs the prior-year figure on file
Versus peers
Medical Devices — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
IRTC
this stock
iRhythm Holdings, Inc.
|
$4.02B | -31.0% | +26.2% | — | 10.4% |
|
ABT
Abbott Laboratories
|
$188.12B | -13.4% | +5.7% | 30.3 | 1.4% |
|
SYK
Stryker Corp
|
$132.87B | +0.5% | +11.2% | 40.1 | 1.8% |
|
MDT
Medtronic plc
|
$111.21B | -8.1% | +8.4% | 23.3 | 1.5% |
|
BSX
Boston Scientific Corp
|
$68.43B | -51.7% | +5.5% | 19.3 | 1.9% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Smart Money
Financials
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| IRTC | +15.4% | +2.9% | -19.7% | +2.9% | -31.0% |
| SPY | -2.4% | -2.3% | +6.3% | -2.3% | +7.0% |
| vs SPY | +17.8% | +5.3% | -26.0% | +5.3% | -38.0% |
Key facts
CIK
1388658
CUSIP
450056106
13F (30d)
58 filings
58 filers
Visit website
Investor relations